Review
Accepted on 21 Oct 2025
Immunomodulatory Roles of Quercetin in Diabetic Nephropathy: Targeting Inflammation, Oxidative Stress, and Ferroptosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1687677
Type at least 3 characters
700 articles
Original Research
Accepted on 20 Oct 2025
Development of a Venous Thromboembolism Risk Prediction Model for Patients with Primary Membranous Nephropathy Based on Machine LearningDevelopment of a Personalized VTE Risk Prediction Model for Patients with Primary Membranous Nephropathy Based on Machine Learning
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1683708
Original Research
Published on 20 Oct 2025
Hemodialysis-induced renal perfusion decline: unraveling the pathophysiological mechanisms linking intradialytic circulatory stress to residual renal function loss
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1648608
- 219 views
General Commentary
Published on 17 Oct 2025
Commentary: Efficacy and safety of HSK21542 for pruritus management in hemodialysis patients: a multicenter, randomized, double-blind, placebo-controlled trial
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1689698
- 708 views
Original Research
Accepted on 16 Oct 2025
Clinical efficacy and safety of Tripterygium wilfordii glycosides in the treatment of idiopathic membranous nephropathy: A Systematic Review and Meta-Analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1652789
- 117 views
Correction
Published on 10 Oct 2025
Correction: Post-translational modifications in sepsis-induced acute kidney injury: mechanisms and perspectives
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1710281
- 800 views
Systematic Review
Published on 10 Oct 2025
Large extracellular vesicles (microvesicles) in diabetic nephropathy: a systematic review of preclinical studies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1622280
- 421 views
Original Research
Published on 08 Oct 2025
Impact of roxadustat on anemia management in infected patients undergoing long-term dialysis: a retrospective cohort analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1695376
- 846 views
Review
Published on 08 Oct 2025
Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678812
- 1,117 views
Editorial
Accepted on 07 Oct 2025
Precise Analysis of Cell Death in Kidney Diseases: Synergistic Breakthroughs in Biomarkers, Mechanisms, and Therapeutics
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1715728
- 135 views
Correction
Accepted on 02 Oct 2025
Correction: Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1710116
- 202 views
Review
Published on 01 Oct 2025
A review of advances in the treatment of diabetic nephropathy by modulating intestinal flora with natural products of traditional Chinese medicine
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1628294
- 777 views
Review
Published on 01 Oct 2025
Acetylation in renal physiology and pathophysiology
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660109
- 869 views
Original Research
Published on 29 Sep 2025
Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1642137
- 1,668 views
Systematic Review
Published on 26 Sep 2025
Discontinuation versus continuation of renin–angiotensin system inhibitors in chronic kidney disease stage 3–5 patients: a systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1646969
- 1,111 views
Original Research
Published on 26 Sep 2025
Optimization of gabapentin dosage in pediatric patients with renal impairment: a physiologically based pharmacokinetic modeling approach
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1669990
- 2,761 views